ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Safety of DLBS1425 as Neoadjuvant in Stage II or III Breast Cancer Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01433562
Recruitment Status : Completed
First Posted : September 14, 2011
Last Update Posted : May 13, 2013
Sponsor:
Information provided by (Responsible Party):
Dexa Medica Group

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : November 2012
  Actual Study Completion Date : November 2012